Lianghe Lu
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
- Hepatology 28
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Oncology 10
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Rong Guo (28 shared papers)Shaohua Li (23 shared papers)Wei Wei (22 shared papers)Jie Mei (22 shared papers)Yihong Ling (14 shared papers)Jingwen Zou (12 shared papers)Wen‐Ping Lin (11 shared papers)Chong Zhong (8 shared papers)
In The Last Decade
Lianghe Lu
38 papers receiving 678 citations
Peers
Comparison fields: 5 of 48
- Hepatology 334
- Oncology 148
- Cancer Research 81
- Epidemiology 80
- Pathology and Forensic Medicine 37
Countries citing papers authored by Lianghe Lu
This map shows the geographic impact of Lianghe Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianghe Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianghe Lu more than expected).
Fields of papers citing papers by Lianghe Lu
This network shows the impact of papers produced by Lianghe Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianghe Lu. The network helps show where Lianghe Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lianghe Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 50 | |
| 2 | 2020 | 47 | |
| 3 | 2021 | 44 | |
| 4 | 2021 | 43 | |
| 5 | 2020 | 37 | |
| 6 | 2020 | 37 | |
| 7 | 2020 | 33 | |
| 8 | 2022 | 31 | |
| 9 | 2021 | 30 | |
| 10 | 2021 | 29 | |
| 11 | 2022 | 24 | |
| 12 | 2021 | 24 | |
| 13 | 2021 | 21 | |
| 14 | 2024 | 21 | |
| 15 | 2020 | 20 | |
| 16 | 2021 | 19 | |
| 17 | 2021 | 18 | |
| 18 | 2021 | 16 | |
| 19 | 2021 | 16 | |
| 20 | 2022 | 16 |
About Lianghe Lu
Lianghe Lu is a scholar working on Hepatology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 41 papers that have together received 682 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Cancer, Lipids, and Metabolism (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Renal cell carcinoma treatment (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Hepatology (334 citations), Oncology (148 citations), Cancer Research (81 citations), Epidemiology (80 citations) and Pathology and Forensic Medicine (37 citations). Lianghe Lu has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Rong Guo, Shaohua Li, Wei Wei, Jie Mei, Yihong Ling, Jingwen Zou, Wen‐Ping Lin, Chong Zhong, Minshan Chen and Yuhua Wen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Medicine, International Journal of Surgery, Journal of Inflammation Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.